Probiotics May Prevent Eczema

May 19, 2009

1 Min Read
SupplySide Supplement Journal logo in a gray background | SupplySide Supplement Journal

UTRECHT, The Netherlands—A probiotic bacteria combination demonstrated a preventive effect on the incidence of eczema in high-risk children, which seemed to be sustained during the first two years of life in a recent Dutch study (Allergy. 2009) (DOI:10.1111/j.1398-9995.2009.02021.x). In the double blind, randomized, placebo-controlled trial, a mixture of probiotic bacteria selected by in-vitro experiments (Bifidobacterium bifidum, Bifidobacterium lactis and Lactococcus lactis; Ecologic® Panda) was prenatally administered to mothers of high-risk children (i.e. positive family history of allergic disease) and to their offspring for the first 12 months of life.

Parental-reported eczema during the first three months of life was significantly lower in the intervention group compared with placebo, 6/50 versus 15/52 (P=0.035). After three months, the incidence of eczema was similar in both groups. Cumulative incidence of parental-reported eczema at one and two years was 23/50 (intervention) versus 31/48 (placebo) and 27 (intervention) versus 34 (placebo), respectively. The number needed to treat was 5.9 at age 3 and 12 months and 6.7 at 2 years old. The intervention group was significantly more frequently colonized with higher numbers of L. lactis. Furthermore, at 3 months old, in vitro production of IL-5 was decreased in the probiotic-group compared with the placebo-group. In addition to previous studies, the preventive effect appears to be established within the first three months of life.

Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.

You May Also Like